Literature DB >> 20235756

Psychological morbidity in ALS: the importance of psychological assessment beyond depression alone.

Stephanie H Felgoise1, Beatrice H Chakraborty, Elisabeth Bond, Jamie Rodriguez, Barbara A Bremer, Susan M Walsh, Eugene C Lai, Leo McCluskey, Zachary Simmons.   

Abstract

The assessment of psychological morbidity in patients with ALS has centered around depression, hopelessness, and anxiety. The Brief Symptom Inventory (BSI) offers an opportunity to explore psychological morbidity more broadly. We administered this instrument to 111 patients with ALS as part of a larger study of quality of life. Scores of ALS patients on the Global Severity Index and Positive Symptom Distress Index were comparable to the majority of distressed psychiatric outpatients and significantly higher than those of non-patient adults. Among BSI subscales, scores on the Anxiety, Depression, Phobic Anxiety, and Somatization subscales also were not significantly different from distressed adult psychiatric outpatients, and were greater than normal mean scores for a non-patient population sample. Based on these data, ALS patients appear to be significantly more distressed than non-patients in the identified areas, and as distressed as approximately 68% of a distressed psychiatric outpatient sample. In conclusion, a substantial number of individuals with ALS experience psychological distress of various types. Because psychological health impacts lifespan and quality of life in these individuals, broadly-based mental health assessment and treatment should remain an important part of care for patients with ALS. The effects of physical symptoms on responses to questions used to assess psychological distress must be considered.

Entities:  

Mesh:

Year:  2010        PMID: 20235756     DOI: 10.3109/17482961003667630

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  8 in total

Review 1.  Clinical diagnosis and management of amyotrophic lateral sclerosis.

Authors:  Orla Hardiman; Leonard H van den Berg; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

2.  Symptom management in amyotrophic lateral sclerosis: We can do better.

Authors:  Stephen A Goutman; Zachary Simmons
Journal:  Muscle Nerve       Date:  2017-08-30       Impact factor: 3.217

3.  Functional Decline is Associated with Hopelessness in Amyotrophic Lateral Sclerosis (ALS).

Authors:  Sabrina Paganoni; Erin McDonnell; David Schoenfeld; Hong Yu; Jing Deng; Hamza Atassi; Alexander Sherman; Padmaja Yerramilli-Rao; Merit Cudkowicz; Nazem Atassi
Journal:  J Neurol Neurophysiol       Date:  2017-04-29

Review 4.  Patient-Perceived Outcomes and Quality of Life in ALS.

Authors:  Zachary Simmons
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

Review 5.  Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis.

Authors:  Sabrina Paganoni; Chafic Karam; Nanette Joyce; Richard Bedlack; Gregory T Carter
Journal:  NeuroRehabilitation       Date:  2015       Impact factor: 2.138

6.  Efficacy of hypnosis-based treatment in amyotrophic lateral sclerosis: a pilot study.

Authors:  Arianna Palmieri; Johann Roland Kleinbub; Vincenzo Calvo; Gianni Sorarù; Irene Grasso; Irene Messina; Marco Sambin
Journal:  Front Psychol       Date:  2012-11-05

7.  An observational study on quality of life and preferences to sustain life in locked-in state.

Authors:  Magdalena Kuzma-Kozakiewicz; Peter M Andersen; Katarzyna Ciecwierska; Cynthia Vázquez; Olga Helczyk; Markus Loose; Ingo Uttner; Albert C Ludolph; Dorothée Lulé
Journal:  Neurology       Date:  2019-08-07       Impact factor: 9.910

8.  Feasibility, acceptability, and potential effectiveness of dignity therapy for people with motor neurone disease.

Authors:  Brenda Bentley; Moira O'Connor; Robert Kane; Lauren J Breen
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.